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Abstract 
Delivery of therapeutic or diagnostic agents to the brain is majorly hindered by the 
blood-brain barrier (BBB). Recently, many studies have demonstrated local and transient 
disruption of the BBB using low power ultrasound sonication combined with intravascular 
microbubbles. However, BBB opening and closure mechanisms are properly understood, 
especially the maximum gap that may be safely generated between endothelial cells and the 
duration of opening of the BBB. Here we studied BBB opening and closure under MR 
guidance in a rat model. First, MR contrast agents (CA) of different hydrodynamic diameters 
(1 – 65 nm) were employed to estimate the largest molecular size permissible across the 
cerebral tissues. Secondly, to estimate the duration of the BBB opening, the CA were injected 
at various times post-BBB disruption (12 min – 24 h). A T1 mapping strategy was developed 
to assess CA concentration at the US focal point. Based on our experimental data and BBB 
closure modeling, a calibration curve was obtained to compute the half closure time as a 
function of CA hydrodynamic diameter. These findings and the model provide an invaluable 
basis for optimal design and delivery of nanoparticles to the brain.  
 
Key words: BBB disruption, MR contrast agent, MRI, T1 mapping, ultrasound, nanoparticles 
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Introduction 
 Cerebral tissues are isolated from circulating blood by the blood brain barrier (BBB) 
(Rubin and Staddon 1999). This physiological barrier consists of a lining of tightly packed 
vascular endothelial cells, different from the peripheral blood vessels (Hawkins and Davis 
2005). The tight junctions between these cells restrict the diffusion of microscopic objects 
(e.g. bacteria) and of large, hydrophilic molecules (>400 Da) from blood to brain 
parenchyma, while allowing the passage of small, hydrophobic molecules such as O2, CO2, 
proteins, and metabolites (Pardridge 2005). Because of the neuroprotective nature of the BBB, 
delivery of potentially important diagnostic and therapeutic agents is a major challenge in the 
treatment of most brain disorders. Strategies to design specific drugs targeted to the brain 
involve finding an efficient mode of drug delivery across the BBB. 
 Recently, it has been demonstrated that the use of low power focused ultrasound 
combined with a systemic injection of lipid- (or polymer-) shelled microbubbles enables a 
non-invasive, local and transient disruption of the BBB (Hynynen et al 2001). Many studies 
were then carried out to (i) establish optimal ultrasound parameters that permit adequate 
tissular penetration without causing tissue damage (Choi et al 2006; Hynynen et al 2005; 
O'Reilly et al 2010; O'Reilly et al 2011a; O'Reilly et al 2011b; Sheikov et al 2008), (ii) 
quantify permeability of the disrupted brain tissue (Vlachos et al 2010; Vlachos et al 2011), 
and (iii) evaluate responses to treatments of particular brain disorders including tumors (Chen 
et al 2010; Liu et al 2010; Treat et al 2009) and Alzheimer’s disease (Jordao et al 2010; 
Raymond et al 2008). Most of these studies used magnetic resonance contrast agents (MR-
CA) for monitoring the processes. 
 Despite a rapidly growing number of studies, the mechanism of ultrasound-induced 
BBB opening is understood only poorly. In particular, the maximum space that can be safely 
generated (ensuring reversibility) between endothelial cells, and the duration for which this 
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opening lasts, have not been measured. The knowledge of these parameters is crucial for the 
current development of brain targeted nanoparticles. Functionalized MR-CA for instance, are 
available in a wide range of hydrodynamic diameters: gadolinium chelates, a few nm 
(Wadghiri et al 2003), iron nanoparticles, 25-100 nm (Mendonca Dias and Lauterbur 1986; 
Renshaw et al 1986), gadolinium based emulsions or liposomes, 200-300 nm (Devoisselle et 
al 1988), and have very different vascular remanences, ranging from a few minutes to tens of 
hours. An estimate of the time window during which a molecule of a given size may be 
delivered across the BBB would be useful to monitor the amount of drug released to cerebral 
tissue and to adjust the dosage. For example, it has been shown that 3 – 8 nm wide particles 
are able to cross BBB 20 min after its ultrasound-induced disruption, but not particles of size 
50 nm (Choi et al 2010). Additionally, as the brain is unprotected while the BBB is open, it is 
important to know the time-to-recovery to limit any possible brain damages induced by 
tissular penetration of pathogenic agents.  
The quantification of the amount of MR-CA crossing the BBB requires development 
of molecular imaging sequences via imaging techniques that are sensitive (high field MRI) 
and provide outputs that can be correlated with the MR-CA concentration. Contrast agent 
(CA) quantification is one of the principal challenges for MR molecular imaging. Unlike 
other techniques such as fluorescence or nuclear imaging where the received signal comes 
directly from the CA, MR signal comes from the surrounding water protons and is therefore 
indirectly related to the presence of an exogenous probe. To quantify the CA concentration 
using MRI, it is necessary to model its interaction with the surrounding water molecules. 
Paramagnetic complexes interact with the surrounding water protons by decreasing their 
relaxation times (Swift and Connick 1962). CA concentration can be linked to the T1 or T2 
relaxation time decrease (in ms). In this study, we adapted a T1 mapping sequence proposed 
by Deichmann and colleagues (Deichmann and Haase 1992; Deichmann et al 1999) that 
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permitted estimation of a wide range of T1 values with a good accuracy, and high spatial and 
temporal resolutions. 
In this study, a calibrated BBB opening procedure was performed in healthy young 
adult rats under MR guidance. Five MR-CA were used (3 paramagnetic and 2 super-
paramagnetic) with different hydrodynamic diameters (from 1 to 65 nm) to investigate the 
maximum permissible size of the gaps induced in the endothelial wall under safe conditions. 
Then, using the T1 mapping strategy for the 3 paramagnetic CA we quantified the amount of 
particles crossing the BBB when injected at different times after ultrasound-induced BBB 
disruption. This enabled quantitative monitoring of the dynamics of BBB closure for each 
given molecular size. Lastly, we present a theoretical model to fit the experimental data and 
derive a calibration curve to predict duration of BBB opening as a function of the 
hydrodynamic diameter of a given CA. 
 
Materials and Methods 
Animal Preparation 
All experiments were performed in accordance with the recommendations of the 
European Community (86/609/EEC) and the French legislation (decree no. 87/848) for use 
and care of laboratory animals. A total of 36 Sprague Dawley male rats (80-100 g, Janvier, 
France) were used. Their head was shaved to ensure proper coupling of the ultrasound beam 
to the brain. Rats were anesthetized with 1.5% isoflurane in a mixture of air and oxygen and 
placed in a cradle in prone position. A catheter (25 G needle) was positioned in the caudal 
vein to inject microbubbles and MR-CA from outside the scanner with minimal dead volume. 
10% heparin was added to all injected solutions to avoid clot formation in the catheter. Body 
temperature and respiration rate were continuously monitored during the experiments.  
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MR-CA 
MR-CA of different hydrodynamic diameters were provided by Guerbet Research 
(France). Main characteristics and injected doses of these nanoparticles are summarized in 
Table 1. After each MR-CA injection, the bolus was flushed by injection of 100 µl of saline 
solution. Three of the five MR-CA were paramagnetic Gd-chelates (Dotarem®, P846, and 
P792) and were detected and quantified using T1 strategies (Kang et al 2010; Protti et al 2010; 
Yankeelov et al 2006). The other two CA (P904 and P03680) were USPIO. A T2 -weighted 
sequence was use to detect them in cerebral tissues (Hyodo et al 2009; Philippens et al 2004). 
Longitudinal r1 and transverse r2 relaxivities were measured in vitro at 7T using galleries of 
tubes containing different concentrations of CA diluted in a 0.3% agar matrix, and maintained 
at 37°C. 
 
Ultrasound equipment 
A MR-compatible focalized transducer (central frequency 1.5 MHz, diameter 30 mm, 
focal depth 20 mm, Imasonic, France) driven by a programmable function generator was used 
to produce ultrasound waves. It was coupled to the rat skull using a latex balloon filled with 
deionized and degassed water. Electrical power sent to the transducer was monitored during 
the BBB opening session. Main characteristics of the transducer (focal point size 
0.6×0.6×3 mm3, transcranial acoustic transmission factor 52 ± 5 %) were estimated in a 
previous study [40]. 
 
BBB opening 
BBB disruption was performed during MR imaging session thanks to a dedicated 
holder maintaining the ultrasound transducer above rat head.  Its position was monitored 
using the ARFI sequence and the right thalamus in the brain was chosen as a target for BBB 
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disruption. Sonovue® microbubbles (Bracco, Italy) were administrated via a bolus (1.5 × 108 
bubbles/ml, 200 µl, 2 s) approximately 5 s before the beginning of ultrasound session. The 
bolus was flushed by injection of 100 µl of saline solution. Sonication was performed with 
3 ms bursts every 100 ms for one minute (Choi et al 2011). The peak negative acoustic 
pressure at the ultrasound focal point was calibrated to 0.45 MPa, a level sufficiently low to 
ensure safe and reversible BBB opening (Larrat et al 2011; Chopra et al 2010). Anatomical 
images were acquired at the end of each MRI session to verify integrity of the brain tissues. 
 
 
MRI acquisitions 
MRI was performed on a 7T/90 mm Pharmascan scanner (Bruker, Germany). A saddle 
coil was specially designed in-house for excitation and signal reception. The geometry and 
size of the resonator (diameter 30 mm) were optimized to maximize the overall signal-to-
noise ratio over the whole brain while allowing the ultrasound beam to propagate from the 
transducer to the rat brain. 
A multislice spin-echo sequence was modified to include additional motion-sensitizing 
gradients, and synchronized to ultrasonic bursts so that the phase signal was proportional to 
local acoustic intensity (Larrat et al 2010; McDannold and Maier 2008). This ARFI sequence 
was acquired with the following parameters: TE/TR = 40/1700 ms, Tacq = 4 min, 
R = 0.5×0.5×1 mm3, duration of the motion encoding gradients = 13.3 ms, duration of the 
sonication = 3 ms. 
A high spatial resolution T2-weighted RARE sequence (TEeff/TR = 32/4200 ms, R = 
0.125×0.125×0.3 mm3) was used to detect the presence of USPIOs, and also for acquiring 
images at the end of every experiment to confirm lack of haemorrhages or edema due to 
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ultrasound. T1-weighted MSME sequence (TE/TR = 8/300 ms, R = 0.250×0.250×1
 mm3) was 
acquired to detect paramagnetic Gd-chelates. 
To measure concentration of Gd-chelates, a T1 mapping sequence was acquired before 
and after MR-CA injection. It consisted in a segmented series of fast gradient echo (FGE) 
images acquired at different time points after magnetization inversion in order to follow the 
entire T1 recovery curve [24, 25]. Sequence parameters were: TR1, 5 ms, TE, 2.5 s, 6 
segments, 60 inversion times (from 64 to 5800 ms), flip angle, 5°, and R =  0.2×0.2×1 mm3. 
Repetition time between the acquisitions of two segments, TR2, was 9 s, and total acquisition 
time is 12.5 min. A centric encoding of the k-space was chosen in order to avoid T2 effects 
during echo trains at the acquisition of central lines. 
 
 
Data analysis 
Data were analyzed using dedicated codes written in Matlab software (MathWorks, 
USA). Maps of acoustic pressure index (IPac) were deduced from ARFI sequence using the 
following equation: 
th
OFFON
ac
P
IP
ϕϕ −
∝                                                  (1) 
where φON (respectively φOFF) is the phase of ARFI signal acquired with ultrasound 
(respectively without ultrasound), and Pth is the expected acoustic pressure at the focal point 
in case of an ideal ultrasound coupling. In a previous study (Larrat et al 2010), we verified the 
linearity between acoustic intensity and MR-ARFI phase signal using the same setup. In 
another study (Larrat et al 2011), we also characterized and verified the linearity between 
acoustic pressure and the amount of MR-CA crossing the BBB in the range of acoustic 
pressure values applied here. 
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To generate T1 maps, the MRI signal measured with the FGE sequence was fitted as a 
function of the inversion time pixel by pixel as proposed by Deichmann and colleagues [24, 
25]. MR-CA concentration maps (C) were then calculated from the T10 and the T1 maps after 
MR-CA injection using the following equation (Swift and Connick 1962), considering that 
relaxivities r1 measured in vitro in agar matrix hardly differ from the ones in rat brain tissues: 






−=
1011
111
TTr
C                                                  (2) 
Signals from different manually drawn ROIs were analyzed. A ROIspot of 0.6×0.6×3 mm
3 
corresponding to the transducer focal point size was drawn in the right thalamus. To analyze 
the effect of BBB disruption, a similar ROIcontra was taken in the corresponding contralateral 
(left thalamus) region of the brain. This enabled correction for the residual vascular 
concentration of MR-CA during imaging. Another control ROI was drawn in an extracerebral 
region in the cheek muscles (ROImuscle). For each rat, a corrected MR-CA concentration at the 
focal point (C* without unit) was calculated as given below, based on the concentration 
measured at the ROIspot (CROIspot) and that at the control spots (CROIcontra and CROImuscle), and 
the index of deposited acoustic pressure (IPac): 
acmuscleROI
contraROIspotROI
IPC
CC
C
.
*
−
=                                              (3) 
This processing step was mandatory to ensure the correction of the bias introduced by unequal 
injected volumes (unequal plasmatic concentrations) and the bias introduced by variations in 
acoustic wave penetration through the skull. These corrections allowed comparing MR-CA 
concentrations among animals. 
 
Results 
Low power, pulsed, ultrasound for localized disruption of BBB 
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In a rat model, BBB was opened transiently with the use of ultrasound, immediately 
followed by intravenous injection of Dotarem® (gadolinium (Gd)-chelate) and measurement 
of the amount of the MR-CA delivered across the BBB (Figure 1). Before the ultrasound 
sonication, acoustic radiation force imaging (ARFI) was performed to obtain the acoustic 
pressure map in the brain (Figure 1-A). This sequence was used to verify that the ultrasound 
beam was focused at the desired point in the right thalamus, and to estimate the acoustic 
pressure at this focal point prior to microbubbles injection, ensuring that the acoustic pressure 
remains below a predetermined safety threshold (Chopra et al 2010; Larrat et al 2011). Once 
the transducer was set at the desired position, Sonovue® microbubbles were injected 
intravenously via a catheter positioned in the caudal vein, and the BBB was disrupted by 
pulsed sonication for one minute. Dotarem® was then injected using the same catheter. To 
measure the concentration of Dotarem® delivered, T1 maps were acquired before and after 
MR-CA injection (Figure 1-B). There was high tissue perfusion of the CA (strong T1 
decrease) in the cheek and neck muscles, but not in the brain tissue due to the BBB. As 
expected, the ultrasound focal point (red arrow) was the only area of the brain exhibiting a 
strong T1 decrease indicating BBB disruption. Based on T1 mapping, CA concentration maps 
were obtained at the three selected regions of interest (ROIs): ultrasound focal point, ROIspot 
(n°1), a control region contralateral to the ultrasound focal point, ROIcontra (n°2) and a region 
in cheek muscles ROIcheeks (n°3) (Figure 1-C). 
 
Maximum gap between endothelial cells after reversible ultrasound-induced disruption 
of the BBB 
In order to determine the size of gaps generated after ultrasound-induced disruption of 
the BBB, we chose five different MR-CA of varying hydrodynamic diameters (Table 1) and 
verified their passage across BBB at the ultrasound focal point. The CA were intravenously 
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injected (n=1 rat for each CA) directly after ultrasound-induced BBB disruption. T1-weighted 
(T1w) images were obtained for the 3 paramagnetic CA and T2-weighted (T2w) images for the 
two ultrasmall superparamagnetic iron oxide (USPIO) CA (Figure 2). For all three Gd-
chelates, a positive contrast was clearly visible on T1w images at the ultrasound focal point, 
revealing the presence of the CA. Student’s t-test performed on the measured MR signals 
confirmed that signal differences between ROIspot and ROIcontra were significant (p < 0.01). 
For the 25 nm USPIO, a negative contrast appeared on T2w images after its injection 
suggesting that BBB was permeable to molecules of this size. Signal differences with 
contralateral region were also significant (p < 0.01). However, the largest USPIO (65 nm) was 
detected only at the very focal point of the transducer as its penetration was significantly 
hindered compared to the smaller USPIO. The signal differences between ROIspot and 
ROIcontra for this USPIO were not significant (p > 0.01) if the ROI was of the standard size 
(0.6×0.6×3 mm3), but the differences became significant (p < 0.01) if the size of the ROIspot 
was decreased to 0.2×0.2×1 mm3 around the focal point. These results suggest that 65 nm is 
close to the maximal gap between endothelial cells that is attainable after BBB disruption 
with this protocol. 
 
Quantification of MR-CA concentration 
Rats were injected with Dotarem® at increasing doses (375, 750 and 1500 µmol/kg, 
n=1 rat per dose) following BBB disruption. Concentration maps acquired by T1 mapping 
were overlaid on the anatomical T2w images (Figure 3-A). Additionally, a T1-weighted 
MSME sequence was also acquired. The estimated CA concentration at the ultrasound focal 
point was found to be proportional to the injected dose (C375 < C750 < C1500) (Figure 3-B). In 
contrast, the T1w signals did not exhibit the same behavior and even saturated at high CA 
injected doses (Figure 3-C). These observations confirm the high interest of our protocol to 
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precisely quantify small variations of CA concentration, and that quantitative analysis based 
on T1w signals alone can be misleading. Hence, results presented in the following sections of 
this study were all derived from quantitative data obtained using the T1 mapping sequence 
(Equation 3). 
 
Quantitative study of BBB closure dynamics 
The BBB closure dynamics was assessed using paramagnetic CA of different 
molecular sizes, administrated at different times after ultrasound-induced disruption. Rats 
were injected with the following CA: Dotarem® (n=10 rats), P846 (n=10 rats) and P792 (n=8 
rats) from 0 to 24 hours after ultrasound sonication. The reproducibility of CA delivery was 
verified by measuring both the injected dose and the acoustic power deposited at the 
ultrasound focal point. CA concentrations measured in the cheek muscles in each animal were 
directly correlated with the injected dose since no permeability barrier like BBB exists in 
muscles (Figure 4-A). Mean values were: 0.345 ± 0.034 mM for Dotarem® group, 
0.061 ± 0.008 mM for P846 group and 0.040 ± 0.002 mM for P792 group. Variabilities 
observed within the above three groups (10%, 13% and 5%, respectively) could be explained 
by experimental errors during injection and also by slight variations in the weight or 
metabolism of the animals. An index of the acoustic pressure (IPac) deposited at the focal 
point was estimated from ARFI sequence (Figure 4-B) and was 1.13 ± 0.06 for Dotarem® 
group, 1.00 ± 0.05 for P846 group and 0.97 ± 0.13 for P792 group. Variabilities observed 
within the above three groups (5%, 5% and 13%, respectively) was mainly explained by slight 
differences in the placement of the transducer on the heads. Variations in the incidence angle 
of the ultrasound beam or in the thickness of the skull could have a significant impact on 
attenuation of the beam during its passage through the skull and lead to variations of the peak-
negative acoustic pressure at the focal point. 
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Corrected CA concentrations (C*) measured at the ultrasound focal point were plotted 
as a function of the time elapsed between BBB disruption and MR-CA injection (Figure 4-C). 
For Dotarem® (1 nm particle), the BBB was permeable for several hours post-BBB 
disruption. A significant amount of CA was detectable in the brain even when injected 8 or 9 
hours after disruption. Around 24 h post-disruption, the BBB had apparently recovered its 
whole integrity, as very few CA were detectable in brain tissues. P846 (4 nm particle) was 
delivered across the BBB only if injected within 2 hours post-BBB disruption. For P792 
(7 nm particle), the duration of CA delivery to the brain was even shorter than for P846. One 
hour post-BBB disruption, the amount of CA crossing the BBB was about 30% of its initial 
value and dropped to undetectable levels after 90 minutes. 
These findings confirmed that the duration of BBB crossing decreases when 
increasing CA hydrodynamic diameter. Secondly, it appears from the shape of the time-
dependent concentration curve (Figure 4-C) that the BBB permeability decreased at a faster 
rate initially and at a lesser rate later on. 
 
A model for BBB closure dynamics 
Based on the experimental observations, the BBB closure dynamics was modelled as 
follows. First, it was assumed that each individual gap generated in the BBB by ultrasound 
returns to its equilibrium position (i.e. closed) as a harmonic oscillator damped by fluid 
friction. The gap diameter as a function of the time was therefore expressed as d(t) = d0e
–kt, 
where d0 is the gap diameter just after BBB disruption and k a time constant representative of 
individual gap closure speed. 
Next, the initial size distribution of gaps was assumed to be a hemi-Gaussian function 
centered on 0 with a standard deviation σ0. These two conditions imply a distribution of gap 
sizes as a function of time expressed as follows: 
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For each time t, the amount QCA(t) of CA of hydrodynamic diameter dH crossing the 
BBB in a unit volume post-disruption is proportional to the inflow flux only, since the 
outflow of CA from brain to blood is assumed to be negligible due to high concentration in 
the blood compartment. Assuming a hard sphere behavior for CA molecules, QCA(t) can be 
expressed as follows: 
∫
+∞
∝
Hd H
CA dx
d
x
txNtQ
2
).,()(                                              (5) 
The CA diffusion in brain outside of the BBB disrupted region is also neglected since the CA 
tissular concentration is quantified within a few minutes after CA intravenous injection. A 
previous study from our team (Marty et al 2010) showed that the Gd-chelates used in this 
study do not diffuse fast enough in brain parenchyma to make this effect significant: for 
example, the diffusion coefficient of Dotarem® (1 nm particle) was estimated around 46 
µm2.s-1 (Table 1). 
Integration of equation 5 gives: 
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    (6) 
All experimental data (n=28 rats) were used to fit this theoretical BBB closure model 
and determine the two parameters: a characteristic gap diameter σ0 = 1.54 nm, and BBB 
closure rate k = 1.54×10-5 s-1. 
The half closure time (t1/2) was then defined as the time after disruption when the 
concentration of CA crossing the BBB was 50% of the maximal concentration obtained 
immediately after disruption. t1/2 was then calculated as the numerical solution of the 
following equation: 
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From the fitted parameters (σ0 and k), half closure times could be estimated as a 
function of hydrodynamic diameters of the molecules by numerically solving equation 7 
(Figure 5, black circles). The calculated half closure time was ~ 5.5 h for a 1 nm particle; 
~ 1.5 h for a 4 nm particle and about 30 min for a 7 nm particle. These values were close to 
those estimated experimentally for Dotarem®, P846 and P792, which were 5.2 h, 1.2 h and 45 
min, respectively (Figure 5, red crosses). 
For larger molecules, half closure times were greatly reduced (around 3 min for a 
25 nm particle and only few seconds for a 65 nm particle). These results match the qualitative 
results obtained with USPIOs (Figure 2). Therefore, to deliver a significant amount of larger 
molecular size CA across the BBB their intravenous circulation should coincide with the end 
of ultrasound sonication. 
Lastly, it appears that the following analytical formula fits reasonably well the 
numerical solution of equation 7, enabling to directly estimate half closure time as a function 
of hydrodynamic diameter: 
22/1
.1 HdB
A
t
+
=                             (8) 
with A = 2.35×104 s and B = 0.2106 nm-2 (Figure 5, solid line). 
 
Discussion 
Ultrasound-induced BBB disruption 
Drug delivery to the brain remains a major challenge for the treatment of most brain 
diseases. Although pathologies such as cancer degrade BBB integrity (Liu et al 2012), it was 
proven that endothelial wall permeability is still poorer in these regions than in vessels of 
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other organs. Recently, ultrasound-induced BBB disruption was demonstrated to be an 
effective method of  significantly increasing permeability of the blood-tumor barrier in a 
controlled manner (Chen et al 2010). Another study reported that vessel wall permeability 
after ultrasound-induced BBB disruption was comparable to permeability values for 
unprotected organs (Vlachos et al 2010). Our study further demonstrates that ultrasound 
combined with intravenous injection of microbubbles is a reliable, reproducible and non-
invasive technique to deliver nanoparticles with hydrodynamic diameters up to 65 nm. 
Moreover, in our protocol, no edema or hemorrhages were detected on T2w images following 
ultrasound sonication. Animals kept alive for several weeks after undergoing BBB disruption 
showed no adverse effects. The observation of a return to basal permeability within 24 hours 
for the smallest available CA (1 nm) further proved that the disruption was transient and 
reversible. 
 
MR guidance 
The ultrasound-induced BBB disruption described here was performed entirely under 
high-field MRI guidance. This is a challenge as it requires integrating a stereotactic frame, a 
MR-compatible ultrasound transducer adapted to the geometry of the rodent head and a 
dedicated radiofrequency (RF) coil fitted into the 8.5 cm bore of a preclinical MRI scanner. 
The optimized RF coil allowed the quantification of Gd MR-CA at a micromolar range, with 
sufficient signal homogeneity over the whole brain and the ability for the ultrasound beam to 
propagate through the coil. 
The anesthetized animal was placed inside the MRI scanner just before the start of the 
BBB disruption procedure till recovery. Thus, it was possible to obtain an acoustic intensity 
map before BBB disruption. This ensured a proper positioning of the ultrasound focal spot in 
the right thalamus and a precise in situ calibration of the acoustic pressure to avoid 
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irreversible tissue damage. Furthermore, microbubbles were injected to cause ultrasound-
induced BBB disruption followed by injection of MR-CA via the same the catheter, which 
allowed imaging of the early events post-BBB disruption. 
 
Maximum gap obtained between endothelial cells 
CA of increasing hydrodynamic sizes were tested, and the maximum gap width 
generated between endothelial cells after BBB disruption was estimated with our acoustic 
parameters. Gaps slightly above 65 nm could be generated safely, and the BBB recovered full 
integrity within 24 h. The mechanical index of our set-up was 0.37 which is below the 
standard value proposed by other studies for reversible BBB opening (McDannold et al 
2008). This result is particularly interesting from the view of development of targeted CA. 
Using a similar sonoporation protocol, it would be possible to deliver nanoparticles such as 
USPIOs, functionalized to target tissular biomarkers. In contrast, larger objects like emulsions 
or liposomes that typically have hydrodynamic diameters >100 nm, would be difficult to 
deliver to the brain using this technique, assuming a purely paracellular pathway. In general, 
an estimate of the maximum possible gap diameter would be helpful when the technique is 
applied to deliver therapeutic molecules. Several therapeutic drugs could benefit from this 
information: for instance chemotherapeutic drugs such as Avastin® (dH ~ 10 nm), 
recombinant adeno-associated virus (rAAV) vectors for gene therapy (dH ~ 20 nm), 
monoclonal antibodies such as anti-β-amyloid (dH of few nm), and vectorized short interfering 
RNA (siRNA) used for gene expression modulation (dH ~ 50 nm). 
The maximum gap diameter measured in this study is probably dependent of the 
sonication parameters, in particular ultrasound frequency, pulse duration and duty cycle, total 
sonication time and size distribution of injected microbubbles (Sonovue® has a broad 
distribution between 1-8 µm). Here, we chose well established parameters that have been 
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proposed by others (Choi et al 2011). Several groups have studied the influence of acoustic 
parameters (O'Reilly et al 2011a) and microbubbles size (Samiotaki 2011) on BBB opening. 
An optimization of parameters based on the knowledge gained from these studies may allow 
generation of pores larger than 65 nm wide. 
 
BBB closure dynamics 
In this study, the concentration of paramagnetic CA delivered at the ultrasound focal 
point was quantitatively measured, based on which, the duration of passage across the BBB 
was estimated for molecules of different sizes. This duration decreased rapidly as a function 
of hydrodynamic diameter of the CA. For instance, small molecules (around 1 nm) continued 
to cross the BBB for more than 10 h, whereas large iron oxide particles (around 25 nm) had a 
time window of only a few minutes. Therefore, to maximize the amount of extravasation in 
the brain, large molecules should be injected right after or even during ultrasound sonication. 
The results presented here also suggest a closure of the BBB at a progressively 
decreasing rate. We present a simple, damped, elastic model assuming an exponential decay 
of individual gap sizes to semi-quantitatively describe the observed dynamics of BBB closure. 
The experimental data were fed in the model to derive important physiological parameters, 
such as the typical closure time constant k that was estimated to be 1.54×10-5 s-1. This 
parameter is an indirect measurement of rate of endothelial cell relaxation after contraction. It 
could be used as a physio-pathological index of vessel integrity. 
This model assumes a paracellular passage of injected molecules with an inflow 
limited by the size of the molecule relative to the size of the pores. Our results support the 
notion that most of the crossing happens between endothelial cells rather than through them. 
This reinforces the hypothesis that during ultrasound-induced BBB opening sonicated 
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microbubbles exert a mechanical stress on endothelial cells which makes them contract on 
themselves and loosen the junctions between them creating gaps (Vykhodtseva et al 2008). 
 
Limitations of the study 
The proposed BBB closure model has certain limitations. It does not take into account 
potential increased permeability of endothelial cell membranes (transcellular BBB crossing). 
It does not distinguish between hydrophilic and lipophilic molecules although it is known that 
lipophilic agents present an increased ability to cross the BBB via transcytosis (Pardridge 
2005). This concurrent release pathway could explain the observed differences between 
experimental data of P846 and P792 and predictions from the theoretical model. 
The three Gd-chelates compared in this study have similar but not equal vascular 
remanences (Table 1). The tissular concentrations were measured within 12.5 minutes after 
CA injection, which is not a negligible time delay as the plasmatic half-life of the CA are 
between 26 and 51 min (Fries et al 2009). Although during data processing the differences in 
overall injected plasmatic concentration were corrected for each CA (Equation 3), temporal 
variations of vascular concentrations during the T1 mapping acquisition could be different 
from one CA to the other, none of them remaining strictly steady. The impact of these 
variations may be low since the MRI mapping acquisition was performed with a centric 
encoding scheme. Nevertheless, it may explain the differences between the theoretical model 
and the experimentally measured closure dynamics for the different molecules. 
 
Conclusion 
In this study, we developed a complete methodology for noninvasive, reversible and 
controlled ultrasound-induced BBB disruption under MR-guidance that permitted precise 
quantification of the amount of MR-CA delivered to brain parenchyma in a rat model. The 
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two key parameters in designing drug delivery across the BBB, namely, the largest 
deliverable molecular size of the agent, and the time window for delivery of an agent of a 
given molecular size, were estimated for the first time. 
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Titles and legends to figures 
 
Figure 1: Different steps of MRI-guided ultrasound-induced disruption of blood-brain 
barrier (BBB). BBB disruption was achieved by intravenous injection of microbubbles via a 
catheter in the tail vein, in conjunction with transcranial ultrasound sonication. This was 
followed by injection of MRI contrast agent (CA) via the same catheter. The entire procedure 
was performed inside a 7T MRI scanner. A. Index of deposited acoustic pressure map derived 
from ARFI images acquired before injection of microbubbles revealed the ultrasound focal 
point. B. T1 maps (in ms) acquired before (Baseline) and after MR-CA injection. C. MR-CA 
concentration map (in mM) derived from corresponding T1 maps. Concentrations from three 
regions of interest (ROIs) were analyzed: ultrasound focal point (n°1), contralateral control 
region (n°2) and extra-cerebral control region in the cheek muscles (n°3). 
 
Figure 2: Ultrasound-induced localized delivery in rat brain of MRI contrast agents 
(CA) with different hydrodynamic diameters. Paramagnetic CA (Dotarem®, P846 and 
P792) or ultrasmall superparamagnetic iron oxide (USPIO) CA (P904 and P03680) were 
injected in rats immediately after ultrasound-induced BBB disruption, and the signal 
intensities were measured within 5 minutes at the ultrasound focal point. T1w images of the 
paramagnetic CA (A, B and C) revealed a positive contrast, while T2w images of the USPIO 
revealed a negative contrast (D and E). Comparison of the signal enhancement in arbitrary 
units (a.u.) in the region of interest of ultrasound focal point (ROIspot, n°1) and that in the 
control contralateral region (ROIcontra, n°2) is given next to the scan corresponding to each CA 
(n = 1 rat for each CA). Differences between the two regions were considered significant for 
p-values < 0.01 (*) using a Student’s t-test. 
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Figure 3: Comparison of T1-weighted (T1w) and T1 mapping strategies to assess the 
amount of Gadolinium (Gd)-chelate crossing the BBB. Dotarem® was injected at different 
doses just after ultrasound-induced BBB disruption in the right thalamus, followed by the 
acquisition of one T1 mapping sequence (to produce a concentration map) and one T1w 
sequence. A. Overlay of CA concentration maps on the corresponding anatomical T2w images 
after injection of increasing doses of Dotarem® (375 , 750 and 1500 µmol/kg, n = 1 rat per 
dose). Purple arrows indicate the ultrasound focal spot where the BBB was disrupted. B. CA 
concentration as estimated using T1 mapping strategy at the ultrasound focal point showing 
linear dependence on the injected dose. C. T1w signal of the CA at the ultrasound focal point 
as a function of the injected dose showing a saturation effect. 
 
Figure 4: BBB closure dynamics after ultrasound induced disruption for MR-CA of 
different molecular sizes. Paramagnetic CA were injected at different times (0 to 24h) after 
BBB disruption. A. Concentrations of the three paramagnetic CA in the region of interest in 
the cheek muscles CROImuscle were measured. B. Index of delivered acoustic pressure at the 
ultrasound focal point in the right thalamus in the brain. The maximum variability within each 
group (CA) for these two parameters was 13 %. C. Corrected concentration (C*) of the CA at 
the ultrasound focal point in the brain was plotted as a function of the time elapsed between 
ultrasound-induced BBB opening and the MR-CA injection (n = 1 rat per time point). All 
experimental data (n=28 rats) were used to fit the theoretical BBB closure model and 
determine the two parameters (σ0 = 1.54 nm, k = 1.54×10
-5 s-1) (Equation 6); dashed lines 
correspond to the fitted data for each MR-CA. 
 
 
 
Figure 5: Prediction of the time window of BBB passage for a given nanoparticle size. 
Based on the theoretical model proposed here, half closure time, t1/2 (the time after 
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ultrasound-induced BBB disruption that is required for the delivery of 50% of the maximal 
dose to the predetermined ultrasound focal point in the brain) was calculated as a function of 
the hydrodynamic diameter of the nanoparticle (Equation 7) (black circles). Red crosses 
correspond to experimental data on the paramagnetic nanoparticle contrast agents used here 
(Dotarem® 1 nm; P846 4 nm; and P792 7 nm) and the solid line represents the best fit with 
analytical unction: t1/2 = A / (1 + B.dH
2), where dH is the hydrodynamic diameter of the 
injected CA (in nm) and A and B are constants, A = 2.35×104 s and B = 0.2106 nm-2.  
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Table 1:  Principal features of the paramagnetic and superparamagnetic nanoparticle 
contrast agents (CA) used in this study. Hydrodynamic diameters (dH) were measured by 
light scattering, longitudinal (r1) and transverse (r2) relaxivities were estimated at 7T in 0.3% 
agar gels maintained at 37°C, vascular remanences were taken from literature (34) and 
diffusion coefficients in brain parenchyma were estimated in a previous work (28). The 
paramagnetic CA were imaged using T1w/T1 mapping sequences, while the superparamagnetic 
using T2w sequences.  
 
 
 dH 
(nm) 
r1 
(mM-1.s-1) 
r2 
(mM-1.s-1) 
Dose 
(µmol/kg 
body weight) 
Vascular 
remanence 
(min) 
Diffusion 
coefficient (× 
10-11 m2.s-1) 
Paramagnetic MR-CA 
Dotarem® <1 3.4 4.8 1500 26 4.6 
P846 4 10.3 37 95 51 1.4 
P792 7 4.9 42 210 32 0.8 
Superparamagnetic MR-CA 
P904 21 1.4 88 1030 - - 
P03680 65 2.0 80 258 - - 
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Different steps of MRI-guided ultrasound-induced disruption of blood-brain barrier (BBB). BBB disruption 
was achieved by intravenous injection of microbubbles via a catheter in the tail vein, in conjunction with 
transcranial ultrasound sonication. This was followed by injection of MRI contrast agent (CA) via the same 
catheter. The entire procedure was performed inside a 7T MRI scanner. A. Index of deposited acoustic 
pressure map derived from ARFI images acquired before injection of microbubbles revealed the ultrasound 
focal point. B. T1 maps (in ms) acquired before (Baseline) and after MR-CA injection. C. MR-CA 
concentration map (in mM) derived from corresponding T1 maps. Concentrations from three regions of 
interest (ROIs) were analyzed: ultr sound focal point (n°1), contralateral control region (n°2) and extra-
cerebral control region in the cheek muscles (n°3).  
160x46mm (300 x 300 DPI)  
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Ultrasound-induced localized delivery in rat brain of MRI contrast agents (CA) with different hydrodynamic 
diameters. Paramagnetic CA (Dotarem®, P846 and P792) or ultrasmall superparamagnetic iron oxide 
(USPIO) CA (P904 and P03680) were injected in rats immediately after ultrasound-induced BBB disruption, 
and the signal intensities were measured within 5 minutes at the ultrasound focal point. T1w images of the 
paramagnetic CA (A, B and C) revealed a positive contrast, while T2w images of the USPIO revealed a 
negative contrast (D and E). Comparison of the signal enhancement in arbitrary units (a.u.) in the region of 
interest of ultrasound focal point (ROIspot, n°1) and that in the control contralateral region (ROIcontra, n°2) is 
given next to the scan corresponding to each CA (n = 1 rat for each CA). Differences between the two 
regions were considered significant for p-values < 0.01 (*) using a Student’s t-test.  
172x97mm (300 x 300 DPI)  
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Figure 3: Comparison of T1-weighted (T1w) and T1 mapping strategies to assess the amount of Gadolinium 
(Gd)-chelate crossing the BBB. Dotarem® was injected at different doses just after ultrasound-induced BBB 
disruption in the right thalamus, followed by the acquisition of one T1 mapping sequence (to produce a 
concentration map) and one T1w sequence. A. Overlay of CA concentration maps on the corresponding 
anatomical T2w images after injection of increasing doses of Dotarem® (375 , 750 and 1500 µmol/kg, n = 1 
rat per dose). Purple arrows indicate the ultrasound focal spot where the BBB was disrupted. B. CA 
concentration as estimated using T1 mapping strategy at the ultrasound focal point showing linear 
dependence on the injected dose. C. T1w signal of the CA at the ultrasound focal point as a function of the 
injected dose showing a saturation effect.  
124x112mm (300 x 300 DPI)  
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Figure 4: BBB closure dynamics after ultrasound induced disruption for MR-CA of different molecular sizes. 
Paramagnetic CA were injected at different times (0 to 24h) after BBB disruption. A. Concentrations of the 
three paramagnetic CA in the region of interest in the cheek muscles CROImuscle were measured. B. Index of 
delivered acoustic pressure at the ultrasound focal point in the right thalamus in the brain. The maximum 
variability within each group (CA) for these two parameters was 13 %. C. Corrected concentration (C*) of 
the CA at the ultrasound focal point in the brain was plotted as a function of the time elapsed between 
ultrasound-induced BBB opening and the MR-CA injection (n = 1 rat per time point). All experimental data 
(n = 28 rats) were used to fit the theoretical BBB closure model and determine the two parameters (σ0 = 
1.54 nm, k = 1.54×10-5 s-1) (Equation 6); dashed lines correspond to the fitted data for each MR-CA.  
172x162mm (300 x 300 DPI)  
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Prediction of the time window of BBB passage for a given nanoparticle size. Based on the theoretical model 
proposed here, half closure time, t1/2 (the time after ultrasound-induced BBB disruption that is required for 
the delivery of 50 % of the maximal dose to the predetermined ultrasound focal point in the brain) was 
calculated as a function of the hydrodynamic diameter of the nanoparticle (Equation 7) (black circles). Red 
crosses correspond to experimental data on the paramagnetic nanoparticle contrast agents used here 
(Dotarem® 1 nm; P846 4 nm; and P792 7 nm) and the solid line represents the best fit with analytical 
function: t1/2 = A / (1 + B.dH
2), where dH is the hydrodynamic diameter of the injected CA (in nm) and A and 
B are constants, A = 2.35×104 s and B = 0.2106 nm-2.  
80x68mm (300 x 300 DPI)  
 
 
Page 33 of 33 Journal of Cerebral Blood Flow and Metabolism
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
